About ScienceInvest

ScienceInvest initially was established in January 2000, together with the publication of a book with Orell Fussli, a renowned Swiss publishing house, on the topic of how to find and use investment relevant information on the internet.

Cooperation’s with large Swiss web portals lead to the publication of weekly newsletters, covering specific topics on the aggregation of publically available information from the internet. In the meantime SI is developing into an internationally networked specialist developing science-based analyses approaches, helping to guide investments with a particular focused on the biotech and medtech arena.

Opposed to numerous other approaches where the target in the investment universe is e.g. through multi-level structuring and selection processes to identify fundamentally attractive companies, SI combines scientific understanding, technical aspects and market data streams in a completely new an innovative way.

The analyses philosophy of ScienceInvest is thus based on the insight, that the combination of a science-based, IT supported and quantitatively driven analyses process eventually provides fundamentally more accurate trigger points and directions in asset management results, than isolated considerations of the individual topics itself.

ScienceInvest is privately held, completely independent and does not participate nor provide specific investment decisions.